Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

All Eyes On The BOE

Published 04/08/2016, 11:12
GBP/USD
-
UK100
-
PRU
-
HIK
-
AV
-

At midday today the Bank of England will unveil its latest monetary policy mix, with widespread expectations for some easing following poor economic data since the EU referendum and dovish comments from voting members of the MPC. With such a major event on the horizon it is unsurprising that the markets are quiet this morning heading into the announcement, with the FTSE 100 and the pound little changed on the day.

Pound supported into rate decision

Rather surprisingly the pound has been performing quite well in recent sessions, despite the weak data and common belief that the BoE will announce easing measures later today. The GBPUSD yesterday touched its highest level in almost 3 weeks at 1.3370, with the previous peak just below the 1.35 level coming the day after the central bank disappointed markets by failing to fulfill expectations for easing. Should the bank under-deliver once more today, we could see a sharp move higher in the pound and a retest of the July highs. With short positioning at a record high in sterling, there is the potential for large moves to the upside on a less dovish than expected statement as shorts would scramble to cover and unwind their positions. Having said that, it’s hard to conceive a scenario that is bullish for the pound over the medium term as even if less aggressive stimulus measures are published at noon, it will increase the likelihood of a relatively more accommodative stance being adopted in the future.

Big moves under the surface

Whilst the index as a whole is broadly flat so far this morning, a closer look at the FTSE 100 reveals some large moves in individual stocks. The biggest mover is Hikma Pharmaceuticals (LON:HIK) which has dropped almost 15% after issuing a disappointing trading update after the market closed last night. The statement that new drug approvals were arriving more slowly than expected and the phasing of litigation costs at US generics have both contributed to the weakness, with analysts at Citi downgrading their recommendation on the stock this morning to further add to its woes. Insurance companies are seeing a boost to their stock price in early trade with Aviva (LON:AV), Prudential (LON:PRU) and Legal & General all near the top of the index.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.